This is near the 52 week low and oversold. With FDA approval coming and customers being added at an increased rate, even with a coming RS, this should rise. Imo.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.